Cancro da mama (Portuguese Wikipedia)

Dunning AM, Healey CS, Pharoah PD, Teare MD, Ponder BA, Easton DF (outubro de 1999). «A systematic review of genetic polymorphisms and breast cancer risk». Cancer Epidemiology, Biomarkers & Prevention. 8 (10): 843–54. PMID 10548311

actamedicaportuguesa.com

Saudade André, Ana Raquel Tomás, Ricardo Fonseca (2005). «Carcinoma da Mama: Determinação da Amplificação do HER2 por Hibridação in situ de Fluorescência (FISH)». Acta Med Port (18): 417-422

ahrq.gov

United States Preventive Services Task Force. «Breast Cancer: Screening». Consultado em 28 de agosto de 2015

aicr.org

Marmot, M; Atinmo, T; Byers, T; Chen, J; Hirohata, T; Jackson, A; James, W; Kolonel, L; Kumanyika, S; Leitzmann, C; Mann, J; Powers, H; Reddy, K; Riboli, E; Rivera, JA; Schatzkin, A; Seidell, J; Shuker, D; Uauy, R; Willett, W; Zeisel, S (2007). Food, Nutrition, Physical Activity, and the Prevention of Cancer: A Global Perspective (PDF). Col: World Cancer Research Fund / American Institute for Cancer Research (AICR) Expert Reports. 2. Washington, DC: AICR. ISBN 9780972252225

archive.is

The Royal Australian and New Zealand College of Obstetricians and Gynaecologists (Novembro de 2014). «Management of the menopause after breast cancer». C-Gyn. 15. Consultado em 7 de Abril de 2016. Arquivado do original em 7 de Abril de 2016

asco.org

Massarut, S; Baldassare G, Belleti B, Reccanello S, D'Andrea S, Ezio C, Perin T, Roncadin M, Vaidya JS (2006). «Intraoperative radiotherapy impairs breast cancer cell motility induced by surgical wound fluid». J Clin Oncol. 24 (18S): 10611

bloomberg.com

Arnst, Catherine (2007). «A Gender Gap in Cancer». Bloomberg Businessweek. ISSN 0007-7135

books.google.com

Saunders, Christobel; Jassal, Sunil (2009). Breast cancer. Oxford: Oxford University Press. p. Capítulo 13. ISBN 978-0-19-955869-8
McCann, Judith A. Shilling (2008). Nursing. Ambler: Lippincott Williams & Wilkins. p. 99. ISBN 978-1-58255-668-0

breastcancercare.org.uk

«Prognosis». Breast Cancer Care UK. Consultado em 27 de junho de 2016

bvs.br

files.bvs.br

Magno Belém Cirqueira, Marise Amaral Rebouças Moreira, Leonardo Ribeiro Soares, Ruffo Freitas-Júnior (Outubro de 2011). «Subtipos moleculares do câncer de mama» (PDF). FEMINA (revisão). 39 (10): 499-503

cancer.gov

National Cancer Insitute (2014). «Breast Cancer Treatment». Consultado em 29 de junho de 2014
National Cancer Institute (2014). «Breast Cancer». Consultado em 29 de junho de 2014
National Cancer Institute (2014). «Breast Cancer Treatment». Consultado em 29 de junho de 2014
National Cancer Institute (2014). «Male Breast Cancer Treatment». Consultado em 29 de junho de 2014
National Cancer Institute (2004). «Metastatic Cancer: Questions and Answers». Consultado em 6 de fevereiro de 2008
«Advances in Breast Cancer Research». National Cancer Institute. 18 de junho de 2020. Consultado em 21 de dezembro de 2020
«Neratinib Maleate». National Cancer Institute. 2 de novembro de 2020. Consultado em 21 de dezembro de 2020
«Olaparib». National Cancer Institute. 6 de agosto de 2020. Consultado em 21 de dezembro de 2020
«Talazoparib Tosylate». National Cancer Institute. 15 de julho de 2020. Consultado em 21 de dezembro de 2020

seer.cancer.gov

«SEER Stat Fact Sheets: Breast Cancer». NCI. Consultado em 18 de junho de 2014. Cópia arquivada em 3 de julho de 2014

cancer.net

«Diagnosis». American Society of Clinical Oncology. Fevereiro de 2016. Consultado em 29 de maio de 2016
«Overview». American Society of Clinical Oncology. Fevereiro de 2016. Consultado em 30 de maio de 2016
«Breast Cancer: Stages». American Society of Clinical Oncology. Fevereiro de 2016. Consultado em 19 de maio de 2016
«Breast Cancer: Stages». American Society of Clinical Oncology. Fevereiro de 2016. Consultado em 9 de maio de 2016
«Breast Cancer - Treatment Options». American Society of Clinical Oncology. Fevereiro de 2016. Consultado em 9 de maio de 2016
«Breast Cancer Treatment». American Society of Clinical Oncology. Consultado em 27 de junho de 2016
«Self Image and Cancer». American Society of Clinical Oncology. Consultado em 21 de maio de 2016
«Anxiety». American Society of Clinical Oncology. Consultado em 21 de maio de 2016

cancer.org

American Cancer Society (2007). «Cancer Facts & Figures 2007» (PDF). Consultado em 26 de abril de 2007. Cópia arquivada (PDF) em 10 de abril de 2007
American Cancer Society (2005). «Breast Cancer Facts & Figures 2005–2006» (PDF). Consultado em 26 de abril de 2007. Cópia arquivada (PDF) em 13 de junho de 2007
«How is breast cancer classified?». American Cancer Society. 4 de maio de 2016. Consultado em 21 de junho de 2016
«Can breast cancer be found early?». American Cancer Society. 4 de maio de 2016. Consultado em 23 de junho de 2016

cancernetwork.com

Peppercorn, J (2009). «Breast Cancer in Women Under 40». Oncology. 23 (6): 465-474

cancerresearchuk.org

«Breast Cancer Staging». Cancer Research UK. Consultado em 19 de maio de 2016

cdc.gov

«Screening». Centers for Disease Control and Prevention. 14 de setembro de 2020. Consultado em 21 de dezembro de 2020

crcfl.net

Riter, Bob (2010). «History of Breast Cancer Advocacy». Cancer Resource Center of the Finger Lakes. Consultado em 29 de junho de 2013. Arquivado do original em 23 de Junho de 2013

dgs.pt

Nuno Miranda, Cristina Portugal (2014). Portugal - Doenças Oncológicas em Números. Lisboa: Direção Geral da Saúde. pp. 11–13

doi.org

dx.doi.org

GBD 2015 Disease and Injury Incidence and Prevalence, Collaborators. (8 de outubro de 2016). «Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015.». Lancet. 388 (10053): 1545–1602. PMC 5055577. PMID 27733282. doi:10.1016/S0140-6736(16)31678-6
GBD 2015 Mortality and Causes of Death, Collaborators. (8 de outubro de 2016). «Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015.». Lancet. 388 (10053): 1459–1544. PMC 5388903. PMID 27733281. doi:10.1016/s0140-6736(16)31012-1
Gøtzsche, PC; Jørgensen KJ (junho de 2013). «Screening for breast cancer with mammography.». The Cochrane database of systematic reviews. 6: CD001877. PMID 23737396. doi:10.1002/14651858.CD001877.pub5
Watson, M (2008). «Assessment of suspected cancer». InnoAiT. 1 (2): 94–107. doi:10.1093/innovait/inn001
Lacroix, M (dezembro de 2006). «Significance, detection and markers of disseminated breast cancer cells». Bioscientifica. Endocrine-related Cancer. 13 (4): 1033–67. PMID 17158753. doi:10.1677/ERC-06-0001
Karakas, C (2011). «Paget's disease of the breast». Journal of carcinogenesis. 10: 31. PMC 3263015. PMID 22279416. doi:10.4103/1477-3163.90676
Hayes, James; Ricahrdson, Ann; Frampton, Chris (Novembro de 2013). «Population attributable risks for modifiable lifestyle factors and breast cancer in New Zealand women». IMJ. 43 (11): 1198–1204. PMID 23910051. doi:10.1111/imj.12256
Reeder, JG; Vogel VG (2008). «Breast cancer prevention.». Cancer treatment and research. 141: 149–64. PMID 18274088. doi:10.1007/978-0-387-73161-2_10
Collaborative Group on Hormonal Factors in Breast Cancer (agosto de 2002). «Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50302 women with breast cancer and 96973 women without the disease.». Lancet. 360 (9328): 187–95. PMID 12133652. doi:10.1016/S0140-6736(02)09454-0
Yager, JD; Davidson NE (2006). «Estrogen carcinogenesis in breast cancer». New Engl J Med. 354 (3): 270–82. PMID 16421368. doi:10.1056/NEJMra050776
Carroll, KK (Novembro de 1998). «Obesity as a risk factor for certain types of cancer». Lipids. 33 (11): 1055-1059. doi:10.1007/s11745-998-0305-8
Johnson, KC; Miller AB; Collishaw NE; Palmer JR; Hammond SK; Salmon AG; Cantor KP; Miller MD; Boyd NF; Millar J; , Turcotte F (janeiro de 2011). «Active smoking and secondhand smoke increase breast cancer risk: the report of the Canadian Expert Panel on Tobacco Smoke and Breast Cancer Risk (2009).». Tobacco control. 20 (1): e2. PMID 21148114. doi:10.1136/tc.2010.035931
Lee, IM; Shiroma EJ; Lobelo F; Puska P; Blair SN; Katzmarzyk PT (Julho de 2012). «Effect of physical inactivity on major non-communicable diseases worldwide: an analysis of burden of disease and life expectancy». The Lancet. 380 (9838): 219–29. PMC 3645500. PMID 22818936. doi:10.1016/S0140-6736(12)61031-9
Biswas, A; Oh PI; Faulkner GE; Bajaj RR; Silver MA; Mitchell MS; Alter DA (2015). «Sedentary Time and Its Association With Risk for Disease Incidence, Mortality, and Hospitalization in Adults: A Systematic Review and Meta-analysis». Annals of Internal Medicine. 162 (2): 123–32. PMID 25599350. doi:10.7326/M14-1651
Boffetta, P; Hashibe M; La Vecchia C; Zatonski W; Rehm J (Agosto de 2006). «The burden of cancer attributable to alcohol drinking». International Journal of Cancer. 119 (4): 884–7. PMID 16557583. doi:10.1002/ijc.21903
Kaiser, J (2013). «Cancer. Cholesterol forges link between obesity and breast cancer.». Science. 342 (6162): 1028. PMID 24288308. doi:10.1126/science.342.6162.1028
Aceves, C; Anguiano B; Delgado G (Abril de 2005). «Is iodine a gatekeeper of the integrity of the mammary gland?». Journal of Mammary Gland Biology and Neoplasia. 10 (2): 189–96. PMID 16025225. doi:10.1007/s10911-005-5401-5
Kahlenborn, C; Modugno F; Potter DM; Severs WB (Outubro de 2006). «Oral contraceptive use as a risk factor for premenopausal breast cancer: a meta-analysis.». Mayo Clinic proceedings. 81 (10): 1290–302. PMID 17036554. doi:10.4065/81.10.1290
Casey, PM; Cerhan JR; Pruthi S (Janeiro de 2008). «Oral contraceptive use and risk of breast cancer.». Mayo Clinic proceedings. 83 (1): 86–90. PMID 18174010. doi:10.4065/83.1.86
Iodice, S; Barile M; Rotmensz N; Feroce I; Bonanni B; Radice P; Bernard L; Maisonneuve P; Gandini S (Agosto de 2010). «Oral contraceptive use and breast or ovarian cancer risk in BRCA1/2 carriers: a meta-analysis.». European journal of cancer. 46 (12): 2275–84. PMID 20537530. doi:10.1016/j.ejca.2010.04.018
Gaffield, ME; Culwell KR; Ravi A (Outubro de 2009). «Oral contraceptives and family history of breast cancer.». Contraception. 80 (4): 372–80. PMID 19751860. doi:10.1016/j.contraception.2009.04.010
Cavalieri E; Chakravarti D; Guttenplan J; Hart E; Ingle J; Jankowiak R; Muti P; Rogan E; Russo J; Santen R; Sutter T (Agosto de 2006). «Catechol estrogen quinones as initiators of breast and other human cancers: implications for biomarkers of susceptibility and cancer prevention». Biochimica et Biophysica Acta. 1766 (1): 63–78. PMID 16675129. doi:10.1016/j.bbcan.2006.03.001
Yang, L; Jacobsen KH (Dezembro de 2008). «A systematic review of the association between breastfeeding and breast cancer.». Journal of Women's Health. 17 (10): 1635–45. PMID 19049358. doi:10.1089/jwh.2008.0917
Beral, V; Bull D; Doll R; Peto R; Reeves G (Março de 2004). «Breast cancer and abortion: collaborative reanalysis of data from 53 epidemiological studies, including 83?000 women with breast cancer from 16 countries.». Lancet. 363 (9414): 1007–16. PMID 15051280. doi:10.1016/S0140-6736(04)15835-2
Wang, XS; Armstrong ME; Cairns BJ; Key TJ; Travis RC (Março de 2011). «Shift work and chronic disease: the epidemiological evidence.». Occupational medicine (Oxford, England). 61 (2): 78–89. PMC 3045028. PMID 21355031. doi:10.1093/occmed/kqr001
Brody, JG; Rudel RA, Michels KB, Moysich KB, Bernstein L, Attfield KR, Gray S (Junho de 2007). «Environmental pollutants, diet, physical activity, body size, and breast cancer: where do we stand in research to identify opportunities for prevention?». Cancer. 109 (12 Suppl): 2627–34. PMID 17503444. doi:10.1002/cncr.22656
Ferro, Roberto (Janeiro de 2012). «Pesticides and Breast Cancer». Advances in Breast Cancer Research. 1 (3): 30–35. doi:10.4236/abcr.2012.13005
Carolyn E. Eberle, Dale P. Sandler, Kyla W. Taylor, Alexandra J. White (3 de dezembro de 2019). «Hair dye and chemical straightener use and breast cancer risk in a large US population of black and white women». Int. J. Cancer. doi:10.1002/ijc.32738
Hendrick, RE (Outubro de 2010). «Radiation doses and cancer risks from breast imaging studies.». Radiology. 257 (1): 246–53. PMID 20736332. doi:10.1148/radiol.10100570
Gage, M; Wattendorf D, Henry LR (2012). «Translational advances regarding hereditary breast cancer syndromes». Journal of surgical oncology. 105 (5): 444–51. PMID 22441895. doi:10.1002/jso.21856
«Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease.». Lancet. 358 (9291): 1389–99. Outubro de 2001. PMID 11705483. doi:10.1016/S0140-6736(01)06524-2
Nelson, HD; Zakher B, Cantor A, Fu R, Griffin J, O'Meara ES, Buist DS, Kerlikowske K, van Ravesteyn NT, Trentham-Dietz A, Mandelblatt JS, Miglioretti DL (2012). «Risk factors for breast cancer for women aged 40 to 49 years: a systematic review and meta-analysis.». Annals of Internal Medicine. 156 (9): 635–48. PMC 3561467. PMID 22547473. doi:10.1059/0003-4819-156-9-201205010-00006
Kouros-Mehr H, Kim JW, Bechis SK, Werb Z (abril de 2008). «GATA-3 and the regulation of the mammary luminal cell fate.». Current opinion in cell biology. 20 (2): 164–70. PMC 2397451. PMID 18358709. doi:10.1016/j.ceb.2008.02.003
Afonso, N; Bouwman D (Agosto de 2008). «Lobular carcinoma in situ». Eur. J. Cancer Prev. 17 (4): 312–6. PMID 18562954. doi:10.1097/CEJ.0b013e3282f75e5d
Anothaisintawee, T; Wiratkapun C, Lerdsitthichai P, Kasamesup V, Wongwaisayawan S, Srinakarin J, Hirunpat S, Woodtichartpreecha P, Boonlikit S, Teerawattananon Y, Thakkinstian A (2013). «Risk factors of breast cancer: a systematic review and meta-analysis». Asian Pacific Journal of Public Health. 25 (5): 368–387. PMID 23709491. doi:10.1177/1010539513488795
Cunha S, Gano L, Morais GR, Thiemann T, Oliveira MC (setembro de 2013). «Progesterone receptor targeting with radiolabelled steroids: an approach in predicting breast cancer response to therapy». J Steroid Biochem Mol Biol. (137): 223-41. doi:10.1016/j.jsbmb.2013.04.003
Haslam SZ, Woodward TL (Junho de 2003). «Host microenvironment in breast cancer development: epithelial-cell-stromal-cell interactions and steroid hormone action in normal and cancerous mammary gland.». Breast Cancer Res. 5 (4): 208–15. PMC 165024. PMID 12817994. doi:10.1186/bcr615
Wiseman BS, Werb Z (Maio de 2002). «Stromal effects on mammary gland development and breast cancer». Science. 296 (5570): 1046–9. PMC 2788989. PMID 12004111. doi:10.1126/science.1067431
Jardé T, Perrier S, Vasson MP, Caldefie-Chézet F (Janeiro de 2011). «Molecular mechanisms of leptin and adiponectin in breast cancer». Eur. J. Cancer. 47 (1): 33–43. PMID 20889333. doi:10.1016/j.ejca.2010.09.005
Begg CB, Haile RW, Borg A, Malone KE, Concannon P, Thomas DC, Langholz B, Bernstein L, Olsen JH, Lynch CF, Anton-Culver H, Capanu M, Liang X, Hummer AJ, Sima C, Bernstein JL (janeiro de 2008). «Variation of breast cancer risk among BRCA1/2 carriers». JAMA. 299 (2): 194–201. PMC 2714486. PMID 18182601. doi:10.1001/jama.2007.55-a
Patel KJ, Yu VP, Lee H, Corcoran A, Thistlethwaite FC, Evans MJ, Colledge WH, Friedman LS, Ponder BA, Venkitaraman AR (Fevereiro de 1998). «Involvement of Brca2 in DNA repair». Mol. Cell. 1 (3): 347–57. PMID 9660919. doi:10.1016/S1097-2765(00)80035-0
Marietta C, Thompson LH, Lamerdin JE, Brooks PJ (Maio de 2009). «Acetaldehyde stimulates FANCD2 monoubiquitination, H2AX phosphorylation, and BRCA1 phosphorylation in human cells in vitro: implications for alcohol-related carcinogenesis». Mutat. Res. 664 (1–2): 77–83. PMC 2807731. PMID 19428384. doi:10.1016/j.mrfmmm.2009.03.011
Theruvathu JA, Jaruga P, Nath RG, Dizdaroglu M, Brooks PJ (2005). «Polyamines stimulate the formation of mutagenic 1,N2-propanodeoxyguanosine adducts from acetaldehyde». Nucleic Acids Res. 33 (11): 3513–20. PMC 1156964. PMID 15972793. doi:10.1093/nar/gki661
Wooster R, Weber BL (junho de 2003). «Breast and ovarian cancer». N. Engl. J. Med. 348 (23): 2339–47. PMID 12788999. doi:10.1056/NEJMra012284
Saslow, D; Hannan J, Osuch J, Alciati MH, Baines C, Barton M, Bobo JK, Coleman C, Dolan M, Gaumer G, Kopans D, Kutner S, Lane DS, Lawson H, Meissner H, Moorman C, Pennypacker H, Pierce P, Sciandra E, Smith R, Coates R (2004). «Clinical breast examination: practical recommendations for optimizing performance and reporting». CA: a cancer journal for clinicians. 54 (6): 327–344. PMID 15537576. doi:10.3322/canjclin.54.6.327
Yu, YH; Liang C, Yuan XZ (2010). «Diagnostic value of vacuum-assisted breast biopsy for breast carcinoma: a meta-analysis and systematic review.». Breast cancer research and treatment. 120 (2): 469–79. PMID 20130983. doi:10.1007/s10549-010-0750-1
Li CI; Uribe DJ; Daling JR (2005). «Clinical characteristics of different histologic types of breast cancer.». Br J Cancer. 93 (9): 1046. doi:10.1038/sj.bjc.6602787
Elston, CW; Ellis IO (1991). «Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up». Histopathology. 19 (5): 403–10. PMID 1757079. doi:10.1111/j.1365-2559.1991.tb00229.x
Eliassen, AH; Hankinson SE, Rosner B, Holmes MD, Willett WC (Outubro de 2010). «Physical activity and risk of breast cancer among postmenopausal women». Arch. Intern. Med. 170 (19): 1758–64. PMC 3142573. PMID 20975025. doi:10.1001/archinternmed.2010.363
Zheng, JS; Hu XJ, Zhao YM, Yang J, Li D (2013). «Intake of fish and marine n-3 polyunsaturated fatty acids and risk of breast cancer: meta-analysis of data from 21 independent prospective cohort studies». BMJ. 346: f3706. PMID 23814120. doi:10.1136/bmj.f3706
Wu, AH; Yu, MC; Tseng, CC; Pike, MC (Janeiro de 2008). «Epidemiology of soy exposures and breast cancer risk.». British journal of cancer. 98 (1): 9–14. PMID 18182974. doi:10.1038/sj.bjc.6604145
Hartmann, LC; Schaid DJ, Woods JE, Crotty TP, Myers JL, Arnold PG, Petty PM, Sellers TA, Johnson JL, McDonnell SK, Frost MH, Jenkins RB (1999). «Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer». N Engl J Med. 340 (2): 77–84. PMID 9887158. doi:10.1056/NEJM199901143400201
Meijers-Heijboer, H; van Geel B, van Putten WL, Henzen-Logmans SC, Seynaeve C, Menke-Pluymers MB, Bartels CC, Verhoog LC, van den Ouweland AM, Niermeijer MF, Brekelmans CT, Klijn JG (2001). «Breast cancer after prophylactic bilateral mastectomy in women with BRCA1 and BRCA2 mutations». N Engl J Med. 345 (3): 159–164. PMID 11463009. doi:10.1056/NEJM200107193450301
Lostumbo, L; Carbine, NE; Wallace, J (Novembro de 2010). «Prophylactic mastectomy for the prevention of breast cancer.». The Cochrane database of systematic reviews (11): CD002748. PMID 21069671. doi:10.1002/14651858.CD002748.pub3
Moyer, VA; U.S. Preventive Services Task Force (Dezembro de 2013). «Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer in Women: U.S. Preventive Services Task Force Recommendation Statement». Annals of Internal Medicine. 160: 271–281. doi:10.7326/M13-2747
Nelson, HD; Smith ME, Griffin JC, Fu R (Abril de 2013). «Use of medications to reduce risk for primary breast cancer: a systematic review for the U.S. Preventive Services Task Force.». Annals of Internal Medicine. 158 (8): 604–14. PMID 23588749. doi:10.7326/0003-4819-158-8-201304160-00005
Cuzick, J; Sestak I, Bonanni B, Costantino JP, Cummings S, DeCensi A, Dowsett M, Forbes JF, Ford L, LaCroix AZ, Mershon J, Mitlak BH, Powles T, Veronesi U, Vogel V, Wickerham DL (2013). «Selective oestrogen receptor modulators in prevention of breast cancer: an updated meta-analysis of individual participant data». The Lancet. 381 (9880): 1827–34. PMID 23639488. doi:10.1016/S0140-6736(13)60140-3
Moyer, VA (2013). «Medications for Risk Reduction of Primary Breast Cancer in Women: U.S. Preventive Services Task Force Recommendation Statement.». Annals of Internal Medicine. PMID 24061472. doi:10.7326/0003-4819-159-10-201311190-00718
Biesheuvel, C; Weigel S, Heindel W (2011). «Mammography Screening: Evidence, History and Current Practice in Germany and Other European Countries.». Breast care (Basel, Switzerland). 6 (2): 104–109. PMID 21673820. doi:10.1159/000327493
Croswell JM, Kramer BS, Kreimer AR (2009). «Cumulative incidence of false-positive results in repeated, multimodal cancer screening». Annals of Family Medicine. 7 (3): 212–22. PMC 2682972. PMID 19433838. doi:10.1370/afm.942
Smith-Bindman R, Ballard-Barbash R, Miglioretti DL, Patnick J, Kerlikowske K (2005). «Comparing the performance of mammography screening in the USA and the UK». Journal of Medical Screening. 12 (1): 50–4. PMID 15814020. doi:10.1258/0969141053279130
Welch, H Gilbert (2006). «Ramifications of screening for breast cancer». British Medical Journal. 332 (7543). PMC 1410868. doi:10.1136/bmj.332.7543.727
«Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement.». Annals of internal medicine. 151 (10): 716–26, W–236. 2009. PMID 19920272. doi:10.1059/0003-4819-151-10-200911170-00008
Kösters, JP; Gøtzsche PC (2003). «Regular self-examination or clinical examination for early detection of breast cancer.». Cochrane Database Syst Rev (2): CD003373. PMID 12804462. doi:10.1002/14651858.CD003373
Kösters JP, Gøtzsche PC (2003). «Regular self-examination or clinical examination for early detection of breast cancer». Cochrane Database Syst Rev (2): CD003373. PMID 12804462. doi:10.1002/14651858.CD003373
Saslow D, Hannan J, Osuch J; et al. (2004). «Clinical breast examination: practical recommendations for optimizing performance and reporting». CA Cancer J Clin. 54 (6): 327–44. PMID 15537576. doi:10.3322/canjclin.54.6.327
Welch, HG, Passow HJ (2013). «Quantifying the Benefits and Harms of Screening Mammography.». JAMA internal medicine. 174 (3): 448–54. PMID 24380095. doi:10.1001/jamainternmed.2013.13635
Gøtzsche, PC; Nielsen M (2011). «Screening for breast cancer with mammography». Cochrane Database Syst Rev (1): CD001877. PMID 21249649. doi:10.1002/14651858.CD001877.pub4
Saini, KS; Taylor C, Ramirez AJ, Palmieri C, Gunnarsson U, Schmoll HJ, Dolci SM, Ghenne C, Metzger-Filho O, Skrzypski M, Paesmans M, Ameye L, Piccart-Gebhart MJ, de Azambuja E (2011). «Role of the multidisciplinary team in breast cancer management: results from a large international survey involving 39 countries». Annals of Oncology. 23 (4): 853–9. PMID 21821551. doi:10.1093/annonc/mdr352
Belletti, B; Vaidya JS, D'Andrea S, Entschladen F, Roncadin M, Lovat F, Berton S, Perin T, Candiani E, Reccanello S, Veronesi A, Canzonieri V, Trovò MG, Zaenker KS, Colombatti A, Baldassarre G, Massarut S (2008). «Targeted intraoperative radiotherapy impairs the stimulation of breast cancer cell proliferation and invasion caused by surgical wounding». Clin. Cancer Res. 14 (5): 1325–32. PMID 18316551. doi:10.1158/1078-0432.CCR-07-4453
Vaidya, JS; Joseph DJ, Tobias JS, Bulsara M, Wenz F, Saunders C, Alvarado M, Flyger HL, Massarut S, Eiermann W, Keshtgar M, Dewar J, Kraus-Tiefenbacher U, Sütterlin M, Esserman L, Holtveg HM, Roncadin M, Pigorsch S, Metaxas M, Falzon M, Matthews A, Corica T, Williams NR, Baum M (2010). «Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority phase 3 trial». Lancet. 376 (9735): 91–102. PMID 20570343. doi:10.1016/S0140-6736(10)60837-9
Burstein, HJ; Temin, S; Anderson, H; Buchholz, TA; Davidson, NE; Gelmon, KE; Giordano, SH; Hudis, CA; Rowden, D; Solky, AJ; Stearns, V; Winer, EP; Griggs, JJ (2014). «Adjuvant Endocrine Therapy for Women With Hormone Receptor-Positive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Focused Update.». Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 32 (21): 2255–69. PMID 24868023. doi:10.1200/JCO.2013.54.2258
Bao, Ting; Rudek, Michelle A (2011). «The Clinical Pharmacology of Anastrozole». European Oncology & Haematology. 7 (2): 106–8. doi:10.17925/EOH.2011.07.02.106
EBCTCG, Early Breast Cancer Trialists' Collaborative Group (Julho de 2015). «Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials». The Lancet. doi:10.1016/S0140-6736(15)61074-1
Petit, T; Dufour P, Tannock I (2011). «A critical evaluation of the role of aromatase inhibitors as adjuvant therapy for postmenopausal women with breast cancer». Endocr. Relat. Cancer. 18 (3): R79–89. PMID 21502311. doi:10.1530/ERC-10-0162
Jahanzeb, M (2008). «Adjuvant trastuzumab therapy for HER2-positive breast cancer». Clin. Breast Cancer. 8 (4): 324–33. PMID 18757259. doi:10.3816/CBC.2008.n.037
Gonzalez-Angulo, AM; Litton JK, Broglio KR, Meric-Bernstam F, Rakkhit R, Cardoso F, Peintinger F, Hanrahan EO, Sahin A, Guray M, Larsimont D, Feoli F, Stranzl H, Buchholz TA, Valero V, Theriault R, Piccart-Gebhart M, Ravdin PM, Berry DA, Hortobagyi GN (2009). «High risk of recurrence for patients with breast cancer who have human epidermal growth factor receptor 2-positive, node-negative tumors 1 cm or smaller». J. Clin. Oncol. 27 (34): 5700–6. PMC 2792998. PMID 19884543. doi:10.1200/JCO.2009.23.2025
Gierach, GL; Ichikawa L, Kerlikowske K, Brinton LA, Farhat GN, Vacek PM, Weaver DL, Schairer C, Taplin SH, Sherman ME (2012). «Relationship between mammographic density and breast cancer death in the Breast Cancer Surveillance Consortium». Journal of National Cancer Institute. 104 (16): 1218–27. PMID 22911616. doi:10.1093/jnci/djs327
Klein, Judith; Ji M, Rea NK, Stoodt G (2011). «Differences in male breast cancer stage, tumor size at diagnosis, and survival rate between metropolitan and nonmetropolitan regions». Am J Mens Health. 5 (5): 430-7. doi:10.1177/1557988311400403
Ramon Luengo-Fernandez, Jose Leal, Alastair Gray, Richard Sullivan (Novembro de 2013). «Economic burden of cancer across the European Union: a population-based cost analysis». The Lancet Oncology. 14 (12): 1165–1174. doi:10.1016/S1470-2045(13)70442-X
Lu J (Agosto de 2015). «Palbociclib: a first-in-class CDK4/CDK6 inhibitor for the treatment of hormone-receptor positive advanced breast cancer». Journal of Hematology & Oncology. 8 (1). 98 páginas. PMC 4534142. PMID 26264704. doi:10.1186/s13045-015-0194-5
André F, Ciruelos E, Rubovszky G, Campone M, Loibl S, Rugo HS, et al. (maio de 2019). «PIK3CA-Mutated, Hormone Receptor-Positive Advanced Breast Cancer». The New England Journal of Medicine. 380 (20): 1929–1940. PMID 31091374. doi:10.1056/NEJMoa1813904
Teicher BA, Doroshow JH (novembro de 2012). «The promise of antibody-drug conjugates». N. Engl. J. Med. 367 (19): 1847–8. PMID 23134386. doi:10.1056/NEJMe1211736
Pazdur, Richard (14 de janeiro de 2011). «FDA Approval for Lapatinib Ditosylate». Cancer.gov. Womens Health (Lond Engl). 6 (2). 173 páginas. PMID 20187722. doi:10.2217/whe.10.11
Rashmi K. Murthy, Sherene Loi, Alicia Okines, Elisavet Paplomata, Erika Hamilton, Sara A. Hurvitz, Nancy U. Lin, Virginia Borges, Vandana Abramson, Carey Anders, Philippe L. Bedard, Mafalda Oliveira; et al. (2020). «Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer». N Engl J Med (382): 597-609. doi:10.1056/NEJMoa1914609
John M. Seligson, Alexandra M. Patron, Michael J. Berger (17 de outubro de 2020). «Sacituzumab Govitecan-hziy: An Antibody-Drug Conjugate for the Treatment of Refractory, Metastatic, Triple-Negative Breast Cancer». Annals of Pharmacotherapy (Revisão). doi:10.1177/1060028020966548
Peter Schmid, Sylvia Adams, Hope S. Rugo, Andreas Schneeweiss, Carlos H. Barrios, Hiroji Iwata, Véronique Diéras, Roberto Hegg, Seock-Ah Im, Gail Shaw Wright, Volkmar Henschel, Luciana Molinero; et al. (29 de novembro de 2018). «Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer». N Engl J Med (379): 2108-2121. doi:10.1056/NEJMoa1809615

emedicine.com

eMedicine (2006). «Breast Cancer Evaluation». Consultado em 5 de fevereiro de 2008

epfl.ch

actu.epfl.ch

Ueberschlag, Leila (4 de março de 2020). «A smart bra for detecting early-stage breast cancer» (em inglês)

esmo.org

Bouche, Gauthier; Piccart, Martine; Pestalozzi, Bernhard; Catane, Raphael (2013). Cancro da Mama: Um Guia Para o Doente (PDF) 3ª ed. [S.l.]: Anticancer Fund. p. 12

eteavare.com.br

Guerra, Maximiliano Ribeiro Guerra; de Moura Gallo, Cláudia Vitória; Azevedo e Silva Mendonça, Gulnar (2005). «Risco de câncer no Brasil: tendências e estudos epidemiológicos mais recentes» (PDF). Revista Brasileira de Cancerologia. 51 (3): 227-234

europepmc.org

Finocchi, L; Covarelli P; Rulli A; Servoli A; Noya G (2008). «Bilateral phylloid cystosarcoma of the breast: a case report and review of the literature». Chirurgia Italiana. 60: 867-872. PMID 19256279

fda.gov

«FDA approves first PI3K inhibitor for breast cancer». Food and Drug Administration (FDA). 24 de maio de 2019. Consultado em 21 de dezembro de 2020
«FDA approves combination of pertuzumab, trastuzumab, and hyaluronidase-zzxf for HER2-positive breast cancer». Food and Drug Administration. 29 de junho de 2020. Consultado em 21 de dezembro de 2020

fspog.com

José Agostinho Santos (2013). «Auto-exame da mama no rastreio do cancro mamário: soma-se a evidência, apaga-se a incerteza» (PDF). Acta Obstet Ginecol Port. 7 (2): 113-117
Araújo, Andreia Monteiro; Centeno, Mónica (2010). «Cancro da mama associado à gravidez» (PDF). Acta Obstet Ginecol Port. 4 (1): 44-52

guardian.co.uk

Browne, Anthony (2001). «Cancer bias puts breasts first». Londres: The Guardian

herceptin.com

«Herceptin (trastuzumab) Adjuvant HER2+ Breast Cancer Therapy Pivotal Studies and Efficacy Data». Herceptin.com. Consultado em 8 de maio de 2010

iarc.fr

International Agency for Research on Cancer (2008). «World Cancer Report» (PDF). Consultado em 26 de fevereiro de 2011

globocan.iarc.fr

OMS, Organização Mundial de Saúde (2012). «Breast Cancer: Estimated Incidence, Mortality and Prevalence Worldwide in 2012». Who.int. Consultado em 30 de agosto de 2015

latimes.com

articles.latimes.com

Aschwanden, Christie (2007). «The trouble with mammograms». Los Angeles Times. Consultado em 3 de setembro de 2015

ligacontracancro.pt

Liga Portuguesa contra o Cancro (2015). «Sinais e sintomas do cancro da mama». Consultado em 23 de agosto de 2015

mayoclinicproceedings.org

Casey, PM; Cerhan JR; Pruthi S (Janeiro de 2008). «Oral contraceptive use and risk of breast cancer.». Mayo Clinic proceedings. 83 (1): 86–90. PMID 18174010. doi:10.4065/83.1.86

merckmanuals.com

Merck Manual (2003). «Breast Disorders: Breast Cancer». Consultado em 5 de fevereiro de 2008
Merck Manual (2003). «Breast Disorders: Overview of Breast Disorders». Consultado em 5 de fevereiro de 2008
Merck Manual (2015). «Breast Cancer». Consultado em 26 de agosto de 2015
Kosir, Mary Ann (2013). «Breast Cancer: Breast Disorders: Merck Manual Professional». Manual Merck. Consultado em 30 de agosto de 2015

min-saude.pt

croc.min-saude.pt

João Moura Pereira (ed.). Cancro da Mama: Protocolo de diagnóstico, terapêutica e seguimento (PDF). [S.l.]: IPO Coimbra. p. 50
Pereira, João Moura; et al. (2012). Cancro da Mama: Protocolo de diagnóstico, terapêutica e seguimento (PDF). [S.l.]: Instituto Português de Oncologia de Coimbra

nejm.org

Rashmi K. Murthy, Sherene Loi, Alicia Okines, Elisavet Paplomata, Erika Hamilton, Sara A. Hurvitz, Nancy U. Lin, Virginia Borges, Vandana Abramson, Carey Anders, Philippe L. Bedard, Mafalda Oliveira; et al. (2020). «Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer». N Engl J Med (382): 597-609. doi:10.1056/NEJMoa1914609
Peter Schmid, Sylvia Adams, Hope S. Rugo, Andreas Schneeweiss, Carlos H. Barrios, Hiroji Iwata, Véronique Diéras, Roberto Hegg, Seock-Ah Im, Gail Shaw Wright, Volkmar Henschel, Luciana Molinero; et al. (29 de novembro de 2018). «Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer». N Engl J Med (379): 2108-2121. doi:10.1056/NEJMoa1809615

nih.gov

ncbi.nlm.nih.gov

GBD 2015 Disease and Injury Incidence and Prevalence, Collaborators. (8 de outubro de 2016). «Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015.». Lancet. 388 (10053): 1545–1602. PMC 5055577. PMID 27733282. doi:10.1016/S0140-6736(16)31678-6
GBD 2015 Mortality and Causes of Death, Collaborators. (8 de outubro de 2016). «Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015.». Lancet. 388 (10053): 1459–1544. PMC 5388903. PMID 27733281. doi:10.1016/s0140-6736(16)31012-1
Gøtzsche, PC; Jørgensen KJ (junho de 2013). «Screening for breast cancer with mammography.». The Cochrane database of systematic reviews. 6: CD001877. PMID 23737396. doi:10.1002/14651858.CD001877.pub5
Nelson, HD; Tyne, K; Naik, A; Bougatsos, C; Chan, B; Nygren, P; Humphrey, L (Novembro de 2009). «Screening for Breast Cancer: Systematic Evidence Review Update for the US Preventive Services Task Force». PMID 20722173
Lacroix, M (dezembro de 2006). «Significance, detection and markers of disseminated breast cancer cells». Bioscientifica. Endocrine-related Cancer. 13 (4): 1033–67. PMID 17158753. doi:10.1677/ERC-06-0001
Karakas, C (2011). «Paget's disease of the breast». Journal of carcinogenesis. 10: 31. PMC 3263015. PMID 22279416. doi:10.4103/1477-3163.90676
Finocchi, L; Covarelli P; Rulli A; Servoli A; Noya G (2008). «Bilateral phylloid cystosarcoma of the breast: a case report and review of the literature». Chirurgia Italiana. 60: 867-872. PMID 19256279
Hayes, James; Ricahrdson, Ann; Frampton, Chris (Novembro de 2013). «Population attributable risks for modifiable lifestyle factors and breast cancer in New Zealand women». IMJ. 43 (11): 1198–1204. PMID 23910051. doi:10.1111/imj.12256
Reeder, JG; Vogel VG (2008). «Breast cancer prevention.». Cancer treatment and research. 141: 149–64. PMID 18274088. doi:10.1007/978-0-387-73161-2_10
Collaborative Group on Hormonal Factors in Breast Cancer (agosto de 2002). «Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50302 women with breast cancer and 96973 women without the disease.». Lancet. 360 (9328): 187–95. PMID 12133652. doi:10.1016/S0140-6736(02)09454-0
Yager, JD; Davidson NE (2006). «Estrogen carcinogenesis in breast cancer». New Engl J Med. 354 (3): 270–82. PMID 16421368. doi:10.1056/NEJMra050776
Johnson, KC; Miller AB; Collishaw NE; Palmer JR; Hammond SK; Salmon AG; Cantor KP; Miller MD; Boyd NF; Millar J; , Turcotte F (janeiro de 2011). «Active smoking and secondhand smoke increase breast cancer risk: the report of the Canadian Expert Panel on Tobacco Smoke and Breast Cancer Risk (2009).». Tobacco control. 20 (1): e2. PMID 21148114. doi:10.1136/tc.2010.035931
Lee, IM; Shiroma EJ; Lobelo F; Puska P; Blair SN; Katzmarzyk PT (Julho de 2012). «Effect of physical inactivity on major non-communicable diseases worldwide: an analysis of burden of disease and life expectancy». The Lancet. 380 (9838): 219–29. PMC 3645500. PMID 22818936. doi:10.1016/S0140-6736(12)61031-9
Biswas, A; Oh PI; Faulkner GE; Bajaj RR; Silver MA; Mitchell MS; Alter DA (2015). «Sedentary Time and Its Association With Risk for Disease Incidence, Mortality, and Hospitalization in Adults: A Systematic Review and Meta-analysis». Annals of Internal Medicine. 162 (2): 123–32. PMID 25599350. doi:10.7326/M14-1651
Blackburn, GL; Wang KA (Setembro de 2007). «Dietary fat reduction and breast cancer outcome: results from the Women's Intervention Nutrition Study (WINS).». The American journal of clinical nutrition. 86 (3): s878–81. PMID 18265482
Boffetta, P; Hashibe M; La Vecchia C; Zatonski W; Rehm J (Agosto de 2006). «The burden of cancer attributable to alcohol drinking». International Journal of Cancer. 119 (4): 884–7. PMID 16557583. doi:10.1002/ijc.21903
Kaiser, J (2013). «Cancer. Cholesterol forges link between obesity and breast cancer.». Science. 342 (6162): 1028. PMID 24288308. doi:10.1126/science.342.6162.1028
Aceves, C; Anguiano B; Delgado G (Abril de 2005). «Is iodine a gatekeeper of the integrity of the mammary gland?». Journal of Mammary Gland Biology and Neoplasia. 10 (2): 189–96. PMID 16025225. doi:10.1007/s10911-005-5401-5
Kahlenborn, C; Modugno F; Potter DM; Severs WB (Outubro de 2006). «Oral contraceptive use as a risk factor for premenopausal breast cancer: a meta-analysis.». Mayo Clinic proceedings. 81 (10): 1290–302. PMID 17036554. doi:10.4065/81.10.1290
Casey, PM; Cerhan JR; Pruthi S (Janeiro de 2008). «Oral contraceptive use and risk of breast cancer.». Mayo Clinic proceedings. 83 (1): 86–90. PMID 18174010. doi:10.4065/83.1.86
Iodice, S; Barile M; Rotmensz N; Feroce I; Bonanni B; Radice P; Bernard L; Maisonneuve P; Gandini S (Agosto de 2010). «Oral contraceptive use and breast or ovarian cancer risk in BRCA1/2 carriers: a meta-analysis.». European journal of cancer. 46 (12): 2275–84. PMID 20537530. doi:10.1016/j.ejca.2010.04.018
Gaffield, ME; Culwell KR; Ravi A (Outubro de 2009). «Oral contraceptives and family history of breast cancer.». Contraception. 80 (4): 372–80. PMID 19751860. doi:10.1016/j.contraception.2009.04.010
Cavalieri E; Chakravarti D; Guttenplan J; Hart E; Ingle J; Jankowiak R; Muti P; Rogan E; Russo J; Santen R; Sutter T (Agosto de 2006). «Catechol estrogen quinones as initiators of breast and other human cancers: implications for biomarkers of susceptibility and cancer prevention». Biochimica et Biophysica Acta. 1766 (1): 63–78. PMID 16675129. doi:10.1016/j.bbcan.2006.03.001
Yang, L; Jacobsen KH (Dezembro de 2008). «A systematic review of the association between breastfeeding and breast cancer.». Journal of Women's Health. 17 (10): 1635–45. PMID 19049358. doi:10.1089/jwh.2008.0917
Russo, J; Russo IH (1980). «Susceptibility of the mammary gland to carcinogenesis. II. Pregnancy interruption as a risk factor in tumor incidence». Am J Pathol. 100 (2): 505–506. PMC 1903536. PMID 6773421. In contrast, abortion is associated with increased risk of carcinomas of the breast. The explanation for these epidemiologic findings is not known, but the parallelism between the DMBA-induced rat mammary carcinoma model and the human situation is striking. ... Abortion would interrupt this process, leaving in the gland undifferentiated structures like those observed in the rat mammary gland, which could render the gland again susceptible to carcinogenesis.
Beral, V; Bull D; Doll R; Peto R; Reeves G (Março de 2004). «Breast cancer and abortion: collaborative reanalysis of data from 53 epidemiological studies, including 83?000 women with breast cancer from 16 countries.». Lancet. 363 (9414): 1007–16. PMID 15051280. doi:10.1016/S0140-6736(04)15835-2
Wang, XS; Armstrong ME; Cairns BJ; Key TJ; Travis RC (Março de 2011). «Shift work and chronic disease: the epidemiological evidence.». Occupational medicine (Oxford, England). 61 (2): 78–89. PMC 3045028. PMID 21355031. doi:10.1093/occmed/kqr001
Brody, JG; Rudel RA, Michels KB, Moysich KB, Bernstein L, Attfield KR, Gray S (Junho de 2007). «Environmental pollutants, diet, physical activity, body size, and breast cancer: where do we stand in research to identify opportunities for prevention?». Cancer. 109 (12 Suppl): 2627–34. PMID 17503444. doi:10.1002/cncr.22656
Hendrick, RE (Outubro de 2010). «Radiation doses and cancer risks from breast imaging studies.». Radiology. 257 (1): 246–53. PMID 20736332. doi:10.1148/radiol.10100570
Gage, M; Wattendorf D, Henry LR (2012). «Translational advances regarding hereditary breast cancer syndromes». Journal of surgical oncology. 105 (5): 444–51. PMID 22441895. doi:10.1002/jso.21856
«Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease.». Lancet. 358 (9291): 1389–99. Outubro de 2001. PMID 11705483. doi:10.1016/S0140-6736(01)06524-2
Nelson, HD; Zakher B, Cantor A, Fu R, Griffin J, O'Meara ES, Buist DS, Kerlikowske K, van Ravesteyn NT, Trentham-Dietz A, Mandelblatt JS, Miglioretti DL (2012). «Risk factors for breast cancer for women aged 40 to 49 years: a systematic review and meta-analysis.». Annals of Internal Medicine. 156 (9): 635–48. PMC 3561467. PMID 22547473. doi:10.1059/0003-4819-156-9-201205010-00006
Kouros-Mehr H, Kim JW, Bechis SK, Werb Z (abril de 2008). «GATA-3 and the regulation of the mammary luminal cell fate.». Current opinion in cell biology. 20 (2): 164–70. PMC 2397451. PMID 18358709. doi:10.1016/j.ceb.2008.02.003
Afonso, N; Bouwman D (Agosto de 2008). «Lobular carcinoma in situ». Eur. J. Cancer Prev. 17 (4): 312–6. PMID 18562954. doi:10.1097/CEJ.0b013e3282f75e5d
Anothaisintawee, T; Wiratkapun C, Lerdsitthichai P, Kasamesup V, Wongwaisayawan S, Srinakarin J, Hirunpat S, Woodtichartpreecha P, Boonlikit S, Teerawattananon Y, Thakkinstian A (2013). «Risk factors of breast cancer: a systematic review and meta-analysis». Asian Pacific Journal of Public Health. 25 (5): 368–387. PMID 23709491. doi:10.1177/1010539513488795
Williams C, Edvardsson K, Lewandowski SA, Stram A, Gustafsson JA. (março de 2008). «A genome-wide study of the repressive effects of estrogen receptor beta on estrogen receptor alpha signaling in breast cancer cells.». Oncogene (27): 1019-1032
Haslam SZ, Woodward TL (Junho de 2003). «Host microenvironment in breast cancer development: epithelial-cell-stromal-cell interactions and steroid hormone action in normal and cancerous mammary gland.». Breast Cancer Res. 5 (4): 208–15. PMC 165024. PMID 12817994. doi:10.1186/bcr615
Wiseman BS, Werb Z (Maio de 2002). «Stromal effects on mammary gland development and breast cancer». Science. 296 (5570): 1046–9. PMC 2788989. PMID 12004111. doi:10.1126/science.1067431
Jardé T, Perrier S, Vasson MP, Caldefie-Chézet F (Janeiro de 2011). «Molecular mechanisms of leptin and adiponectin in breast cancer». Eur. J. Cancer. 47 (1): 33–43. PMID 20889333. doi:10.1016/j.ejca.2010.09.005
Dunning AM, Healey CS, Pharoah PD, Teare MD, Ponder BA, Easton DF (outubro de 1999). «A systematic review of genetic polymorphisms and breast cancer risk». Cancer Epidemiology, Biomarkers & Prevention. 8 (10): 843–54. PMID 10548311
Begg CB, Haile RW, Borg A, Malone KE, Concannon P, Thomas DC, Langholz B, Bernstein L, Olsen JH, Lynch CF, Anton-Culver H, Capanu M, Liang X, Hummer AJ, Sima C, Bernstein JL (janeiro de 2008). «Variation of breast cancer risk among BRCA1/2 carriers». JAMA. 299 (2): 194–201. PMC 2714486. PMID 18182601. doi:10.1001/jama.2007.55-a
Patel KJ, Yu VP, Lee H, Corcoran A, Thistlethwaite FC, Evans MJ, Colledge WH, Friedman LS, Ponder BA, Venkitaraman AR (Fevereiro de 1998). «Involvement of Brca2 in DNA repair». Mol. Cell. 1 (3): 347–57. PMID 9660919. doi:10.1016/S1097-2765(00)80035-0
Marietta C, Thompson LH, Lamerdin JE, Brooks PJ (Maio de 2009). «Acetaldehyde stimulates FANCD2 monoubiquitination, H2AX phosphorylation, and BRCA1 phosphorylation in human cells in vitro: implications for alcohol-related carcinogenesis». Mutat. Res. 664 (1–2): 77–83. PMC 2807731. PMID 19428384. doi:10.1016/j.mrfmmm.2009.03.011
Theruvathu JA, Jaruga P, Nath RG, Dizdaroglu M, Brooks PJ (2005). «Polyamines stimulate the formation of mutagenic 1,N2-propanodeoxyguanosine adducts from acetaldehyde». Nucleic Acids Res. 33 (11): 3513–20. PMC 1156964. PMID 15972793. doi:10.1093/nar/gki661
Wooster R, Weber BL (junho de 2003). «Breast and ovarian cancer». N. Engl. J. Med. 348 (23): 2339–47. PMID 12788999. doi:10.1056/NEJMra012284
Saslow, D; Hannan J, Osuch J, Alciati MH, Baines C, Barton M, Bobo JK, Coleman C, Dolan M, Gaumer G, Kopans D, Kutner S, Lane DS, Lawson H, Meissner H, Moorman C, Pennypacker H, Pierce P, Sciandra E, Smith R, Coates R (2004). «Clinical breast examination: practical recommendations for optimizing performance and reporting». CA: a cancer journal for clinicians. 54 (6): 327–344. PMID 15537576. doi:10.3322/canjclin.54.6.327
Yu, YH; Liang C, Yuan XZ (2010). «Diagnostic value of vacuum-assisted breast biopsy for breast carcinoma: a meta-analysis and systematic review.». Breast cancer research and treatment. 120 (2): 469–79. PMID 20130983. doi:10.1007/s10549-010-0750-1
Carlson, RW; Allred DC, Anderson BO, Burstein HJ, Carter WB, Edge SB, Erban JK, Farrar WB, Goldstein LJ, Gradishar WJ, Hayes DF, Hudis CA, Jahanzeb M, Kiel K, Ljung BM, Marcom PK, Mayer IA, McCormick B, Nabell LM, Pierce LJ, Reed EC, Smith ML, Somlo G, Theriault RL, Topham NS, Ward JH, Winer EP, Wolff AC (2009). «Breast cancer. Clinical practice guidelines in oncology». Journal of the National Comprehensive Cancer Network : JNCCN. 7 (2): 122–192. PMID 19200416
Elston, CW; Ellis IO (1991). «Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up». Histopathology. 19 (5): 403–10. PMID 1757079. doi:10.1111/j.1365-2559.1991.tb00229.x
Eliassen, AH; Hankinson SE, Rosner B, Holmes MD, Willett WC (Outubro de 2010). «Physical activity and risk of breast cancer among postmenopausal women». Arch. Intern. Med. 170 (19): 1758–64. PMC 3142573. PMID 20975025. doi:10.1001/archinternmed.2010.363
Zheng, JS; Hu XJ, Zhao YM, Yang J, Li D (2013). «Intake of fish and marine n-3 polyunsaturated fatty acids and risk of breast cancer: meta-analysis of data from 21 independent prospective cohort studies». BMJ. 346: f3706. PMID 23814120. doi:10.1136/bmj.f3706
Wu, AH; Yu, MC; Tseng, CC; Pike, MC (Janeiro de 2008). «Epidemiology of soy exposures and breast cancer risk.». British journal of cancer. 98 (1): 9–14. PMID 18182974. doi:10.1038/sj.bjc.6604145
Hartmann, LC; Schaid DJ, Woods JE, Crotty TP, Myers JL, Arnold PG, Petty PM, Sellers TA, Johnson JL, McDonnell SK, Frost MH, Jenkins RB (1999). «Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer». N Engl J Med. 340 (2): 77–84. PMID 9887158. doi:10.1056/NEJM199901143400201
Meijers-Heijboer, H; van Geel B, van Putten WL, Henzen-Logmans SC, Seynaeve C, Menke-Pluymers MB, Bartels CC, Verhoog LC, van den Ouweland AM, Niermeijer MF, Brekelmans CT, Klijn JG (2001). «Breast cancer after prophylactic bilateral mastectomy in women with BRCA1 and BRCA2 mutations». N Engl J Med. 345 (3): 159–164. PMID 11463009. doi:10.1056/NEJM200107193450301
Lostumbo, L; Carbine, NE; Wallace, J (Novembro de 2010). «Prophylactic mastectomy for the prevention of breast cancer.». The Cochrane database of systematic reviews (11): CD002748. PMID 21069671. doi:10.1002/14651858.CD002748.pub3
Nelson, HD; Smith ME, Griffin JC, Fu R (Abril de 2013). «Use of medications to reduce risk for primary breast cancer: a systematic review for the U.S. Preventive Services Task Force.». Annals of Internal Medicine. 158 (8): 604–14. PMID 23588749. doi:10.7326/0003-4819-158-8-201304160-00005
Cuzick, J; Sestak I, Bonanni B, Costantino JP, Cummings S, DeCensi A, Dowsett M, Forbes JF, Ford L, LaCroix AZ, Mershon J, Mitlak BH, Powles T, Veronesi U, Vogel V, Wickerham DL (2013). «Selective oestrogen receptor modulators in prevention of breast cancer: an updated meta-analysis of individual participant data». The Lancet. 381 (9880): 1827–34. PMID 23639488. doi:10.1016/S0140-6736(13)60140-3
Moyer, VA (2013). «Medications for Risk Reduction of Primary Breast Cancer in Women: U.S. Preventive Services Task Force Recommendation Statement.». Annals of Internal Medicine. PMID 24061472. doi:10.7326/0003-4819-159-10-201311190-00718
Biesheuvel, C; Weigel S, Heindel W (2011). «Mammography Screening: Evidence, History and Current Practice in Germany and Other European Countries.». Breast care (Basel, Switzerland). 6 (2): 104–109. PMID 21673820. doi:10.1159/000327493
Croswell JM, Kramer BS, Kreimer AR (2009). «Cumulative incidence of false-positive results in repeated, multimodal cancer screening». Annals of Family Medicine. 7 (3): 212–22. PMC 2682972. PMID 19433838. doi:10.1370/afm.942
Smith-Bindman R, Ballard-Barbash R, Miglioretti DL, Patnick J, Kerlikowske K (2005). «Comparing the performance of mammography screening in the USA and the UK». Journal of Medical Screening. 12 (1): 50–4. PMID 15814020. doi:10.1258/0969141053279130
Welch, H Gilbert (2006). «Ramifications of screening for breast cancer». British Medical Journal. 332 (7543). PMC 1410868. doi:10.1136/bmj.332.7543.727
«Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement.». Annals of internal medicine. 151 (10): 716–26, W–236. 2009. PMID 19920272. doi:10.1059/0003-4819-151-10-200911170-00008
Kösters, JP; Gøtzsche PC (2003). «Regular self-examination or clinical examination for early detection of breast cancer.». Cochrane Database Syst Rev (2): CD003373. PMID 12804462. doi:10.1002/14651858.CD003373
Nelson HD, Tyne K, Naik A; et al. (2009). Screening for Breast Cancer: Systematic Evidence Review Update for the US Preventive Services Task Force. Col: Evidence Syntheses, 74. Rockville: Agency for Healthcare Research and Quality (US)
Kösters JP, Gøtzsche PC (2003). «Regular self-examination or clinical examination for early detection of breast cancer». Cochrane Database Syst Rev (2): CD003373. PMID 12804462. doi:10.1002/14651858.CD003373
Saslow D, Hannan J, Osuch J; et al. (2004). «Clinical breast examination: practical recommendations for optimizing performance and reporting». CA Cancer J Clin. 54 (6): 327–44. PMID 15537576. doi:10.3322/canjclin.54.6.327
Nelson HD, Tyne K, Naik A; et al. (novembro de 2009). «Screening for Breast Cancer: Systematic Evidence Review Update for the US Preventive Services Task Force». Agency for Healthcare Research and Quality. Evidence Syntheses (74) .
Welch, HG, Passow HJ (2013). «Quantifying the Benefits and Harms of Screening Mammography.». JAMA internal medicine. 174 (3): 448–54. PMID 24380095. doi:10.1001/jamainternmed.2013.13635
Gøtzsche, PC; Nielsen M (2011). «Screening for breast cancer with mammography». Cochrane Database Syst Rev (1): CD001877. PMID 21249649. doi:10.1002/14651858.CD001877.pub4
Saini, KS; Taylor C, Ramirez AJ, Palmieri C, Gunnarsson U, Schmoll HJ, Dolci SM, Ghenne C, Metzger-Filho O, Skrzypski M, Paesmans M, Ameye L, Piccart-Gebhart MJ, de Azambuja E (2011). «Role of the multidisciplinary team in breast cancer management: results from a large international survey involving 39 countries». Annals of Oncology. 23 (4): 853–9. PMID 21821551. doi:10.1093/annonc/mdr352
Belletti, B; Vaidya JS, D'Andrea S, Entschladen F, Roncadin M, Lovat F, Berton S, Perin T, Candiani E, Reccanello S, Veronesi A, Canzonieri V, Trovò MG, Zaenker KS, Colombatti A, Baldassarre G, Massarut S (2008). «Targeted intraoperative radiotherapy impairs the stimulation of breast cancer cell proliferation and invasion caused by surgical wounding». Clin. Cancer Res. 14 (5): 1325–32. PMID 18316551. doi:10.1158/1078-0432.CCR-07-4453
Vaidya, JS; Joseph DJ, Tobias JS, Bulsara M, Wenz F, Saunders C, Alvarado M, Flyger HL, Massarut S, Eiermann W, Keshtgar M, Dewar J, Kraus-Tiefenbacher U, Sütterlin M, Esserman L, Holtveg HM, Roncadin M, Pigorsch S, Metaxas M, Falzon M, Matthews A, Corica T, Williams NR, Baum M (2010). «Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority phase 3 trial». Lancet. 376 (9735): 91–102. PMID 20570343. doi:10.1016/S0140-6736(10)60837-9
Burstein, HJ; Temin, S; Anderson, H; Buchholz, TA; Davidson, NE; Gelmon, KE; Giordano, SH; Hudis, CA; Rowden, D; Solky, AJ; Stearns, V; Winer, EP; Griggs, JJ (2014). «Adjuvant Endocrine Therapy for Women With Hormone Receptor-Positive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Focused Update.». Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 32 (21): 2255–69. PMID 24868023. doi:10.1200/JCO.2013.54.2258
Petit, T; Dufour P, Tannock I (2011). «A critical evaluation of the role of aromatase inhibitors as adjuvant therapy for postmenopausal women with breast cancer». Endocr. Relat. Cancer. 18 (3): R79–89. PMID 21502311. doi:10.1530/ERC-10-0162
Jahanzeb, M (2008). «Adjuvant trastuzumab therapy for HER2-positive breast cancer». Clin. Breast Cancer. 8 (4): 324–33. PMID 18757259. doi:10.3816/CBC.2008.n.037
NCBI, National Center for Biotechnology Information (2015). «ERBB2 erb-b2 receptor tyrosine kinase 2 Homo sapiens (human)». Consultado em 28 de agosto de 2015
Gonzalez-Angulo, AM; Litton JK, Broglio KR, Meric-Bernstam F, Rakkhit R, Cardoso F, Peintinger F, Hanrahan EO, Sahin A, Guray M, Larsimont D, Feoli F, Stranzl H, Buchholz TA, Valero V, Theriault R, Piccart-Gebhart M, Ravdin PM, Berry DA, Hortobagyi GN (2009). «High risk of recurrence for patients with breast cancer who have human epidermal growth factor receptor 2-positive, node-negative tumors 1 cm or smaller». J. Clin. Oncol. 27 (34): 5700–6. PMC 2792998. PMID 19884543. doi:10.1200/JCO.2009.23.2025
Gierach, GL; Ichikawa L, Kerlikowske K, Brinton LA, Farhat GN, Vacek PM, Weaver DL, Schairer C, Taplin SH, Sherman ME (2012). «Relationship between mammographic density and breast cancer death in the Breast Cancer Surveillance Consortium». Journal of National Cancer Institute. 104 (16): 1218–27. PMID 22911616. doi:10.1093/jnci/djs327
McNaught J, Reid RL, Provencher DM (julho de 2006). «Progesterone-only and non-hormonal contraception in the breast cancer survivor: Joint Review and Committee Opinion of the Society of Obstetricians and Gynaecologists of Canada and the Society of Gynecologic Oncologists of Canada». J Obstet Gynaecol Can. 28 (7): 616–39. PMID 16924781
Azim, HA; Santoro, L; Russell-Edu, W; Pentheroudakis, G; Pavlidis, N; Peccatori, FA (Novembro de 2012). «Prognosis of pregnancy-associated breast cancer: a meta-analysis of 30 studies.». Cancer treatment reviews. 38 (7): 834–42. PMID 22785217
Lu J (Agosto de 2015). «Palbociclib: a first-in-class CDK4/CDK6 inhibitor for the treatment of hormone-receptor positive advanced breast cancer». Journal of Hematology & Oncology. 8 (1). 98 páginas. PMC 4534142. PMID 26264704. doi:10.1186/s13045-015-0194-5
André F, Ciruelos E, Rubovszky G, Campone M, Loibl S, Rugo HS, et al. (maio de 2019). «PIK3CA-Mutated, Hormone Receptor-Positive Advanced Breast Cancer». The New England Journal of Medicine. 380 (20): 1929–1940. PMID 31091374. doi:10.1056/NEJMoa1813904
Teicher BA, Doroshow JH (novembro de 2012). «The promise of antibody-drug conjugates». N. Engl. J. Med. 367 (19): 1847–8. PMID 23134386. doi:10.1056/NEJMe1211736
Pazdur, Richard (14 de janeiro de 2011). «FDA Approval for Lapatinib Ditosylate». Cancer.gov. Womens Health (Lond Engl). 6 (2). 173 páginas. PMID 20187722. doi:10.2217/whe.10.11

nichd.nih.gov

«Klinefelter Syndrome». Eunice Kennedy Shriver National Institute of Child Health and Human Development. 24 de maio de 2007. Arquivado do original em 27 de novembro de 2012

obgyn.net

Pritchard, KI (2009). «Ovarian Suppression/Ablation in Premenopausal ER-Positive Breast Cancer Patients». Oncology. 23 (1)

ons.gov.uk

«Cancer Survival in England: Patients Diagnosed 2007–2011 and Followed up to 2012» (PDF). Office for National Statistics. 29 de outubro de 2013. Consultado em 29 de junho de 2014. Cópia arquivada (PDF) em 29 de novembro de 2014

prwatch.org

Landeman, Anne (2001). «Pinkwashing: Can Shopping Cure Breast Cancer?». Center for Media and Democracy

ranzcog.edu.au

The Royal Australian and New Zealand College of Obstetricians and Gynaecologists (Novembro de 2014). «Management of the menopause after breast cancer». C-Gyn. 15. Consultado em 7 de Abril de 2016. Arquivado do original em 7 de Abril de 2016

rbac.org.br

«Predisposição hereditária ao câncer de mama e sua relação com os genes BRCA1 e BRCA2: revisão da literatura». Revista RBAC. Consultado em 21 de maio de 2021

reuters.com

in.reuters.com

Reuters (2015). «Oldest evidence of breast cancer found in Egyptian skeleton». Consultado em 25 de março de 2015

sabcs.org

Adrian Lee; Carlos Arteaga (14 de dezembro de 2009). 32nd Annual CTRC-AACR San Antonio Breast Cancer Symposium (PDF). Sunday Morning Year-End Review. [S.l.: s.n.] Consultado em 6 de Fevereiro de 2016. Arquivado do original (PDF) em 13 de Agosto de 2013

sagepub.com

journals.sagepub.com

John M. Seligson, Alexandra M. Patron, Michael J. Berger (17 de outubro de 2020). «Sacituzumab Govitecan-hziy: An Antibody-Drug Conjugate for the Treatment of Refractory, Metastatic, Triple-Negative Breast Cancer». Annals of Pharmacotherapy (Revisão). doi:10.1177/1060028020966548

springer.com

link.springer.com

Carroll, KK (Novembro de 1998). «Obesity as a risk factor for certain types of cancer». Lipids. 33 (11): 1055-1059. doi:10.1007/s11745-998-0305-8

stopcancerfund.org

NCI, National Cancer Institute and the National Research Center for Women & Families (2004). «Surgery Choices for Women with Early Stage Breast Cancer» (PDF). Consultado em 30 de agosto de 2015. Arquivado do original (PDF) em 13 de Agosto de 2013

techexplorist.com

«SmartBra to detect cancer at the earliest stages» (em inglês). 3 de abril de 2020

thelancet.com

Cuzick, J; Sestak I, Bonanni B, Costantino JP, Cummings S, DeCensi A, Dowsett M, Forbes JF, Ford L, LaCroix AZ, Mershon J, Mitlak BH, Powles T, Veronesi U, Vogel V, Wickerham DL (2013). «Selective oestrogen receptor modulators in prevention of breast cancer: an updated meta-analysis of individual participant data». The Lancet. 381 (9880): 1827–34. PMID 23639488. doi:10.1016/S0140-6736(13)60140-3
EBCTCG, Early Breast Cancer Trialists' Collaborative Group (Julho de 2015). «Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials». The Lancet. doi:10.1016/S0140-6736(15)61074-1
Ramon Luengo-Fernandez, Jose Leal, Alastair Gray, Richard Sullivan (Novembro de 2013). «Economic burden of cancer across the European Union: a population-based cost analysis». The Lancet Oncology. 14 (12): 1165–1174. doi:10.1016/S1470-2045(13)70442-X

touchoncology.com

Bao, Ting; Rudek, Michelle A (2011). «The Clinical Pharmacology of Anastrozole». European Oncology & Haematology. 7 (2): 106–8. doi:10.17925/EOH.2011.07.02.106

ulusofona.pt

recil.ulusofona.pt

Ribeiro, Joana Inácio (2014). Carcinoma mamário: estado da arte (PDF). Lisboa: Faculdade de Ciências e Tecnologias da Saúde

up.pt

repositorio-aberto.up.pt

Dias, Ana Margarida de Azevedo (2010). Inibidores da aromatase e cancro da mama: Avaliação biológica de novas moléculas esteroides. [S.l.]: Faculdade de Farmácia da Universidade do Porto

uspreventiveservicestaskforce.org

US Preventative Services Task Force (2009). «Screening for Breast Cancer». Consultado em 24 de dezembro de 2012
«Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement.». Annals of internal medicine. 151 (10): 716–26, W–236. 2009. PMID 19920272. doi:10.1059/0003-4819-151-10-200911170-00008

web.archive.org

«Klinefelter Syndrome». Eunice Kennedy Shriver National Institute of Child Health and Human Development. 24 de maio de 2007. Arquivado do original em 27 de novembro de 2012
«SEER Stat Fact Sheets: Breast Cancer». NCI. Consultado em 18 de junho de 2014. Cópia arquivada em 3 de julho de 2014
«Cancer Survival in England: Patients Diagnosed 2007–2011 and Followed up to 2012» (PDF). Office for National Statistics. 29 de outubro de 2013. Consultado em 29 de junho de 2014. Cópia arquivada (PDF) em 29 de novembro de 2014
American Cancer Society (2007). «Cancer Facts & Figures 2007» (PDF). Consultado em 26 de abril de 2007. Cópia arquivada (PDF) em 10 de abril de 2007
American Cancer Society (2005). «Breast Cancer Facts & Figures 2005–2006» (PDF). Consultado em 26 de abril de 2007. Cópia arquivada (PDF) em 13 de junho de 2007
Adrian Lee; Carlos Arteaga (14 de dezembro de 2009). 32nd Annual CTRC-AACR San Antonio Breast Cancer Symposium (PDF). Sunday Morning Year-End Review. [S.l.: s.n.] Consultado em 6 de Fevereiro de 2016. Arquivado do original (PDF) em 13 de Agosto de 2013
NCI, National Cancer Institute and the National Research Center for Women & Families (2004). «Surgery Choices for Women with Early Stage Breast Cancer» (PDF). Consultado em 30 de agosto de 2015. Arquivado do original (PDF) em 13 de Agosto de 2013
«Breast cancer burden». Organização Mundial de Saúde. Consultado em 18 de maio de 2016. Arquivado do original em 6 de Setembro de 2015
Riter, Bob (2010). «History of Breast Cancer Advocacy». Cancer Resource Center of the Finger Lakes. Consultado em 29 de junho de 2013. Arquivado do original em 23 de Junho de 2013

webmd.com

WebMD. «Breast Cancer and Mammograms». Consultado em 24 de dezembro de 2012

who.int

OMS, Organização Mundial de Saúde (201). «WHO Disease and injury country estimates». Consultado em 30 de agosto de 2015
«Breast cancer burden». Organização Mundial de Saúde. Consultado em 18 de maio de 2016. Arquivado do original em 6 de Setembro de 2015

wikipedia.org

en.wikipedia.org

The Royal Australian and New Zealand College of Obstetricians and Gynaecologists (Novembro de 2014). «Management of the menopause after breast cancer». C-Gyn. 15. Consultado em 7 de Abril de 2016. Arquivado do original em 7 de Abril de 2016

wkhealth.com

meta.wkhealth.com

Afonso, N; Bouwman D (Agosto de 2008). «Lobular carcinoma in situ». Eur. J. Cancer Prev. 17 (4): 312–6. PMID 18562954. doi:10.1097/CEJ.0b013e3282f75e5d

worldcat.org

Sulik, Gayle A. (2010). Pink Ribbon Blues: How Breast Cancer Culture Undermines Women's Health. [S.l.]: Oxford University Press. pp. 200–3. ISBN 0-19-974045-3. OCLC 535493589
Arnst, Catherine (2007). «A Gender Gap in Cancer». Bloomberg Businessweek. ISSN 0007-7135